Vtv Therapeutics INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Samsara BioCapital, L.P. reported a sale of 75,965 shares of VTV Therapeutics Class A Common Stock at $21.25 per share in a private transaction.
NASDAQ
Samsara BioCapital and Samsara Opportunity Fund increased their beneficial ownership in VTV Therapeutics Inc. Class A Common Stock to 9.9% following a $15.0 million private placement.
NASDAQ
VTV Therapeutics Inc. has entered into a securities purchase agreement for a private placement totaling $25 million, involving Samsara BioCapital funds.